Polanczyk C A, Newton C, Dec G W, Di Salvo T G
Heart Failure and Cardiac Transplantation Unit, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
J Card Fail. 2001 Dec;7(4):289-98. doi: 10.1054/jcaf.2001.28931.
The effect of hospital quality of care on hospital readmission for patients with congestive heart failure (CHF) has not been widely studied.
We examined the effects of clinical factors, hospital quality of care, and cardiologist involvement on 3-month readmission rates in patients with CHF by using a 125-item explicit review instrument comprising 3 major domains: admission work-up, evaluation and treatment, and readiness for discharge. During the 3 months after discharge, 59 (30%) of 205 patients were readmitted for CHF. The average evaluation and treatment score was lower for readmitted patients (63% v 58%; P = .04). The specific quality criteria differing between patients readmitted or not readmitted included the performance of any diagnostic evaluation, performance of echocardiography in patients with unknown ejection fraction or suspected valvular disease, and therapy with an angiotensin-converting enzyme inhibitor on discharge. Patients with <or=50% of the evaluation and treatment criteria met were more likely to be readmitted (odds ratio, 2.5; 95% confidence interval, 1.1-5.3; P = .02). In a multivariate model including both clinical characteristics and quality criteria, a low evaluation and treatment score was an independent predictor of readmission. Cardiologist involvement was correlated with higher quality-of-care scores in the admission work-up (4.8% higher; P < .01) and evaluation and treatment (8.6% higher; P < .0001).
Hospital quality of care for patients with CHF is independently associated with 3-month readmission rates, and cardiologist involvement during hospitalization is associated with overall quality of care.
医院护理质量对充血性心力衰竭(CHF)患者再次入院的影响尚未得到广泛研究。
我们使用一个包含125个项目的明确审查工具,该工具涵盖3个主要领域:入院检查、评估与治疗以及出院准备情况,来研究临床因素、医院护理质量和心脏病专家参与情况对CHF患者3个月再入院率的影响。出院后的3个月内,205例患者中有59例(30%)因CHF再次入院。再次入院患者的平均评估与治疗得分较低(63%对58%;P = 0.04)。再次入院和未再次入院患者之间存在差异的具体质量标准包括进行任何诊断评估、对射血分数未知或疑似瓣膜疾病患者进行超声心动图检查以及出院时使用血管紧张素转换酶抑制剂治疗。达到评估与治疗标准不足50%的患者更有可能再次入院(比值比,2.5;95%置信区间,1.1 - 5.3;P = 0.02)。在一个包括临床特征和质量标准的多变量模型中,低评估与治疗得分是再入院的独立预测因素。心脏病专家的参与与入院检查(高4.8%;P < 0.01)和评估与治疗(高8.6%;P < 0.0001)中更高的护理质量得分相关。
CHF患者的医院护理质量与3个月再入院率独立相关,住院期间心脏病专家的参与与整体护理质量相关。